Specialized Biomarker or Genomic Analysis
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract opportunity, titled Specialized Biomarker or Genomic Analysis, involves performing high-complexity laboratory testing on specimens for prime contractors supporting Department of Defense breast cancer research projects. The scope of work includes executing genomic sequencing, proteomics, or immunohistochemistry using Mass Spectrometers and Next-Generation Sequencing platforms. The selected provider must deliver comprehensive laboratory analysis reports and raw data files. The contract is managed by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541715. To be eligible, providers must hold ISO/IEC 17025 or CLIA certification. The solicitation was posted on September 3, 2026, with a response deadline of November 18, 2026.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of HT942526BCRPCREA2.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
DoW Breast Cancer, Clinical Research Extension Award
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
Same awarding agency
